National Health Investors (NHI) Reports In-Line Q2 FFO
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $70.39 +0.28%
Financial Fact:
Franchise, excise and other taxes: 271K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Franchise, excise and other taxes: 271K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
National Health Investors (NYSE: NHI) reported Q2 EPS of $1.38, in-line with the analyst estimate of $1.38.
GUIDANCE:
National Health Investors sees FY2018 EPS of $5.47-$5.51, versus the consensus of $5.50.
For earnings history and earnings-related data on National Health Investors (NHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Oddity Tech Ltd. (ODD) Tops Q2 EPS by 1c
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
